208 related articles for article (PubMed ID: 32878777)
1. Effect of Phosphoribosyltransferase Down-regulation on Malignant Glioma Cell Characteristics.
Kamada M; Ikeda K; Manome Y
Anticancer Res; 2020 Sep; 40(9):4895-4905. PubMed ID: 32878777
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the nicotinamide adenine dinucleotide (NAD) salvage pathway, to target glioma heterogeneity through mitochondrial oxidative stress.
Sharma P; Xu J; Williams K; Easley M; Elder JB; Lonser R; Lang FF; Lapalombella R; Sampath D; Puduvalli VK
Neuro Oncol; 2022 Feb; 24(2):229-244. PubMed ID: 34260721
[TBL] [Abstract][Full Text] [Related]
3. Expression patterns of nicotinamide phosphoribosyltransferase and nicotinic acid phosphoribosyltransferase in human malignant lymphomas.
Olesen UH; Hastrup N; Sehested M
APMIS; 2011 Apr; 119(4-5):296-303. PubMed ID: 21492230
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity.
Soncini D; Caffa I; Zoppoli G; Cea M; Cagnetta A; Passalacqua M; Mastracci L; Boero S; Montecucco F; Sociali G; Lasigliè D; Damonte P; Grozio A; Mannino E; Poggi A; D'Agostino VG; Monacelli F; Provenzani A; Odetti P; Ballestrero A; Bruzzone S; Nencioni A
J Biol Chem; 2014 Dec; 289(49):34189-204. PubMed ID: 25331943
[TBL] [Abstract][Full Text] [Related]
5. Supplementation of nicotinic acid with NAMPT inhibitors results in loss of in vivo efficacy in NAPRT1-deficient tumor models.
O'Brien T; Oeh J; Xiao Y; Liang X; Vanderbilt A; Qin A; Yang L; Lee LB; Ly J; Cosino E; LaCap JA; Ogasawara A; Williams S; Nannini M; Liederer BM; Jackson P; Dragovich PS; Sampath D
Neoplasia; 2013 Dec; 15(12):1314-29. PubMed ID: 24403854
[TBL] [Abstract][Full Text] [Related]
6. Retinal toxicity, in vivo and in vitro, associated with inhibition of nicotinamide phosphoribosyltransferase.
Zabka TS; Singh J; Dhawan P; Liederer BM; Oeh J; Kauss MA; Xiao Y; Zak M; Lin T; McCray B; La N; Nguyen T; Beyer J; Farman C; Uppal H; Dragovich PS; O'Brien T; Sampath D; Misner DL
Toxicol Sci; 2015 Mar; 144(1):163-72. PubMed ID: 25505128
[TBL] [Abstract][Full Text] [Related]
7. Silencing of NAMPT leads to up-regulation of insulin receptor substrate 1 gene expression in U87 glioma cells.
Tsymbal DO; Minchenko DO; Luzina OY; Riabovol OO; Danilovskyi SV; Minchenko OH
Endocr Regul; 2020 Jan; 54(1):31-42. PubMed ID: 32597148
[TBL] [Abstract][Full Text] [Related]
8.
Lucena-Cacace A; Otero-Albiol D; Jiménez-García MP; Muñoz-Galvan S; Carnero A
Clin Cancer Res; 2018 Mar; 24(5):1202-1215. PubMed ID: 29203587
[No Abstract] [Full Text] [Related]
9. Different Effects of RNAi-Mediated Downregulation or Chemical Inhibition of NAMPT in an Isogenic IDH Mutant and Wild-Type Glioma Cell Model.
Clausing M; William D; Preussler M; Biedermann J; Grützmann K; Richter S; Buchholz F; Temme A; Schröck E; Klink B
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628596
[TBL] [Abstract][Full Text] [Related]
10. Nicotinamide phosphoribosyl transferase regulates cell growth via the Sirt1/P53 signaling pathway and is a prognosis marker in colorectal cancer.
Pan JH; Zhou H; Zhu SB; Huang JL; Zhao XX; Ding H; Qin L; Pan YL
J Cell Physiol; 2019 Apr; 234(4):4385-4395. PubMed ID: 30191976
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel resistance mechanisms to NAMPT inhibition via the de novo NAD
Guo J; Lam LT; Longenecker KL; Bui MH; Idler KB; Glaser KB; Wilsbacher JL; Tse C; Pappano WN; Huang TH
Biochem Biophys Res Commun; 2017 Sep; 491(3):681-686. PubMed ID: 28756225
[TBL] [Abstract][Full Text] [Related]
12. Small interfering RNA-mediated silencing of nicotinamide phosphoribosyltransferase (NAMPT) and lysosomal trafficking regulator (LYST) induce growth inhibition and apoptosis in human multiple myeloma cells: A preliminary study.
Bong IP; Ng CC; Fakiruddin SK; Lim MN; Zakaria Z
Bosn J Basic Med Sci; 2016 Nov; 16(4):268-275. PubMed ID: 27754828
[TBL] [Abstract][Full Text] [Related]
13. Targeting NAD metabolism regulates extracellular adenosine levels to improve the cytotoxicity of CD8+ effector T cells in the tumor microenvironment of gastric cancer.
Liu HY; Wang FH; Liang JM; Xiang YY; Liu SH; Zhang SW; Zhu CM; He YL; Zhang CH
J Cancer Res Clin Oncol; 2023 Jul; 149(7):2743-2756. PubMed ID: 35776198
[TBL] [Abstract][Full Text] [Related]
14. The endogenous tryptophan metabolite and NAD+ precursor quinolinic acid confers resistance of gliomas to oxidative stress.
Sahm F; Oezen I; Opitz CA; Radlwimmer B; von Deimling A; Ahrendt T; Adams S; Bode HB; Guillemin GJ; Wick W; Platten M
Cancer Res; 2013 Jun; 73(11):3225-34. PubMed ID: 23548271
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of NAMPT expression by mir-206 reduces cell survival of breast cancer cells.
Hesari Z; Nourbakhsh M; Hosseinkhani S; Abdolvahabi Z; Alipour M; Tavakoli-Yaraki M; Ghorbanhosseini SS; Yousefi Z; Jafarzadeh M; Yarahmadi S
Gene; 2018 Oct; 673():149-158. PubMed ID: 29886033
[TBL] [Abstract][Full Text] [Related]
16. Inhibitor of Nicotinamide Phosphoribosyltransferase Sensitizes Glioblastoma Cells to Temozolomide via Activating ROS/JNK Signaling Pathway.
Feng J; Yan PF; Zhao HY; Zhang FC; Zhao WH; Feng M
Biomed Res Int; 2016; 2016():1450843. PubMed ID: 28097126
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway.
Wang LF; Wang XN; Huang CC; Hu L; Xiao YF; Guan XH; Qian YS; Deng KY; Xin HB
Lipids Health Dis; 2017 Apr; 16(1):82. PubMed ID: 28449683
[TBL] [Abstract][Full Text] [Related]
18. Perturbations of NAD
Agerholm M; Dall M; Jensen BAH; Prats C; Madsen S; Basse AL; Graae AS; Risis S; Goldenbaum J; Quistorff B; Larsen S; Vienberg SG; Treebak JT
Am J Physiol Endocrinol Metab; 2018 Apr; 314(4):E377-E395. PubMed ID: 29208611
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of NAMPT expression by miR-182 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.
Chen XY; Zhang HS; Wu TC; Sang WW; Ruan Z
Int J Biochem Cell Biol; 2013 Feb; 45(2):292-8. PubMed ID: 23153509
[TBL] [Abstract][Full Text] [Related]
20. NAMPT overexpression alleviates alcohol-induced hepatic steatosis in mice.
Xiong X; Yu J; Fan R; Zhang C; Xu L; Sun X; Huang Y; Wang Q; Ruan HB; Qian X
PLoS One; 2019; 14(2):e0212523. PubMed ID: 30794635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
